Danish life-science company raises EUR 30 millions in fundings

We have advised Danish life-science company Bactolife with its raise of EUR 30 million in one of the largest bioindustrial Series A funding rounds in Europe. The fundings will help Bactolife commercialise its most mature products and further strengthen its technology platform.

Bactolife develops proprietary Bindings Proteins TM, which strengthen the gut microbiome of humans and animals with the aim of reducing the burden of gastrointestinal infections and anti-microbial resistance – ultimately reducing the need for antibiotic treatment and the spread of antibiotic resistant bacteria on a global scale.